Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants

Vaccines are considered one of the greatest medical achievements in the battle against infectious diseases. However, the intractability of various diseases such as hepatitis C, HIV/AIDS, malaria, tuberculosis, and cancer poses persistent hurdles given that traditional vaccine-development methods have proven to be ineffective; as such, these challenges have driven the emergence of novel vaccine design approaches. In this regard, much effort has been put into the development of new safe adjuvants and vaccine platforms. Of particular interest, the utilization of plant virus-like nanoparticles and recombinant plant viruses has gained increasing significance as an effective tool in the development of novel vaccines against infectious diseases and cancer. The present review summarizes recent advances in the use of plant viruses as nanoparticle-based vaccines and adjuvants and their mechanism of action. Harnessing plant-virus immunogenic properties will enable the design of novel, safe, and efficacious prophylactic and therapeutic vaccines against disease.

• Publication year

  2015

• Venue

  Vaccines

• Publication date

  2015-08-05

• Fields of study

  Biology, Medicine, Materials Science, Environmental Science

• Identifiers
  DOI 10.3390/vaccines3030620PMID 26350598PMCID 4586470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A transgenic plant cell-suspension system for expression of epitopes on chimeric Bamboo mosaic virus particles.

  2016cited by this paper
• Broadening the repertoire of melanoma-associated T-cell epitopes

  2015cited by this paper
• T cell responses in hepatitis C virus infection: historical overview and goals for future research.

  2015cited by this paper
• Plant Virus Particles Carrying Tumour Antigen Activate TLR7 and Induce High Levels of Protective Antibody

  2015influential reference
• Immunogenicity of Newcastle disease virus vectors expressing Norwalk virus capsid protein in the presence or absence of VP2 protein.

  2015cited by this paper
• Cytotoxic activities of CD8+ T cells collaborate with macrophages to protect against blood-stage murine malaria

  2015cited by this paper
• Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice

  2015cited by this paper
• HIV Control Is Mediated in Part by CD8+ T-Cell Targeting of Specific Epitopes

  2014cited by this paper
• Protective immunity against malaria after vaccination

  2014cited by this paper
• Pre-existing immunity against Ad vectors

  2014cited by this paper
• Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles.

  2014cited by this paper
• Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge

  2014cited by this paper
• High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma

  2014cited by this paper
• Characterization of the Protective HIV-1 CTL Epitopes and the Corresponding HLA Class I Alleles: A Step towards Designing CTL Based HIV-1 Vaccine

  2014cited by this paper
• Protective immunity against malaria after vaccination.

  2014cited by this paper
• Tobacco mosaic virus efficiently targets DC uptake, activation and antigen-specific T cell responses in vivo.

  2014cited by this paper
• High-Level Systemic Expression of Conserved Influenza Epitope in Plants on the Surface of Rod-Shaped Chimeric Particles

  2014cited by this paper
• Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP

  2013cited by this paper
• A Plant-Produced Pfs25 VLP Malaria Vaccine Candidate Induces Persistent Transmission Blocking Antibodies against Plasmodium falciparum in Immunized Mice

  2013cited by this paper
• Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus.

  2013cited by this paper
• This information is current as Infection Listeria Monocytogenes Protection from Mediated − T Cell + Enhances CD 8 Nanoparticle Adjuvant Sensing by TLR 7

  2013influential reference
• Identification of Targets of CD8+ T Cell Responses to Malaria Liver Stages by Genome-wide Epitope Profiling

  2013cited by this paper
• Induction of innate immunity in lungs with virus-like nanoparticles leads to protection against influenza and Streptococcus pneumoniae challenge.

  2013influential reference
• Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors.

  2013cited by this paper
• In vivo self-assembly of TMV-like particles in yeast and bacteria for nanotechnological applications.

  2013cited by this paper
• Chinese biotech partnership brings first hepatitis E vaccine to the market.

  2012cited by this paper
• Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine.

  2012cited by this paper
• Immunogenic compositions assembled from tobacco mosaic virus-generated spherical particle platforms and foreign antigens.

  2012cited by this paper
• Engineering of Papaya Mosaic Virus (PapMV) Nanoparticles through Fusion of the HA11 Peptide to Several Putative Surface-Exposed Sites

  2012cited by this paper
• Induction of protective immunity in chickens immunized with plant-made chimeric Bamboo mosaic virus particles expressing very virulent Infectious bursal disease virus antigen.

  2012cited by this paper
• Mapping the surface‐exposed regions of papaya mosaic virus nanoparticles

  2012cited by this paper
• Ovarian cancer vaccine candidate DPX-Survivac: positive interim results from phase 1.

  2012cited by this paper
• Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens.

  2012cited by this paper
• Chimeric Trop2 Virus-like Particles: A Potential Immunotherapeutic Approach Against Pancreatic Cancer

  2011cited by this paper
• Improvement of the Trivalent Inactivated Flu Vaccine Using PapMV Nanoparticles

  2011influential reference
• Vesicular Stomatitis Virus as a Vector To Deliver Virus-Like Particles of Human Norovirus: a New Vaccine Candidate against an Important Noncultivable Virus

  2011cited by this paper
• New Viral Vector for Superproduction of Epitopes of Vaccine Proteins in Plants

  2011cited by this paper
• Characteristics of Artificial Virus-like Particles Assembled in vitro from Potato Virus X Coat Protein and Foreign Viral RNAs

  2011cited by this paper
• Relationship between the size of nanoparticles and their adjuvant activity: data from a study with an improved experimental design.

  2011cited by this paper
• Thermal transition of native tobacco mosaic virus and RNA-free viral proteins into spherical nanoparticles.

  2011cited by this paper
• Expression of Human papillomavirus 16 E7ggg oncoprotein on N- and C-terminus of Potato virus X coat protein in bacterial and plant cells.

  2011cited by this paper
• Cross‐presentation of epitopes on virus‐like particles via the MHC I receptor recycling pathway

  2011cited by this paper
• Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees

  2011cited by this paper
• In vitro assembly of Tobacco mosaic virus coat protein variants derived from fission yeast expression clones or plants.

  2010cited by this paper
• Cucumber mosaic virus as the expression system for a potential vaccine against Alzheimer's disease.

  2010cited by this paper
• Immunogenic properties of chimeric potato virus X particles displaying the hepatitis C virus hypervariable region I peptide R9.

  2010cited by this paper
• Two distinct chimeric potexviruses share antigenic cross-presentation properties of MHC class I epitopes.

  2010cited by this paper
• Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients

  2010cited by this paper
• The influence of innate and pre‐existing immunity on adenovirus therapy

  2009cited by this paper
• Efficient generation of cowpea mosaic virus empty virus-like particles by the proteolytic processing of precursors in insect cells and plants.

  2009cited by this paper
• Interaction of Cowpea Mosaic Virus (CPMV) Nanoparticles with Antigen Presenting Cells In Vitro and In Vivo

  2009cited by this paper
• Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice.

  2009cited by this paper
• Virus-like Particle (VLP) Lymphatic Trafficking and Immune Response Generation After Immunization by Different Routes

  2009cited by this paper
• Type I interferon signaling in dendritic cells stimulates the development of lymph-node-resident T follicular helper cells.

  2009cited by this paper
• Tomato bushy stunt virus (TBSV), a versatile platform for polyvalent display of antigenic epitopes and vaccine design.

  2009influential reference
• The who, how and where of antigen presentation to B cells

  2009cited by this paper
• Vaccines: correlates of vaccine-induced immunity.

  2008cited by this paper
• Translating innate response into long‐lasting antibody response by the intrinsic antigen‐adjuvant properties of papaya mosaic virus

  2008influential reference
• Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response.

  2008cited by this paper
• Cowpea mosaic virus capsid: a promising carrier for the development of carbohydrate based antitumor vaccines.

  2008cited by this paper
• Antitumor Activity of DNA Vaccines Based on the Human Papillomavirus-16 E7 Protein Genetically Fused to a Plant Virus Coat Protein

  2008cited by this paper
• Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform.

  2008cited by this paper
• Inactivation and purification of cowpea mosaic virus-like particles displaying peptide antigens from Bacillus anthracis.

  2007cited by this paper
• Novel Plant Virus-Based Vaccine Induces Protective Cytotoxic T-Lymphocyte-Mediated Antiviral Immunity through Dendritic Cell Maturation

  2007influential reference
• Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus

  2007cited by this paper
• Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens.

  2007cited by this paper
• Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization.

  2007cited by this paper
• A new and versatile virosomal antigen delivery system to induce cellular and humoral immune responses.

  2007cited by this paper
• Cucumber mosaic virus as a presentation system for a double hepatitis C virus-derived epitope

  2007cited by this paper
• Anti‐Carbohydrate Antibodies Elicited by Polyvalent Display on a Viral Scaffold

  2007cited by this paper
• Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes

  2007cited by this paper
• Chemical conjugate TMV-peptide bivalent fusion vaccines improve cellular immunity and tumor protection.

  2006cited by this paper
• A modified TMV-based vector facilitates the expression of longer foreign epitopes in tobacco.

  2006cited by this paper
• In planta production of two peptides of the Classical Swine Fever Virus (CSFV) E2 glycoprotein fused to the coat protein of potato virus X

  2006cited by this paper
• Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.

  2006cited by this paper
• Genetic stability of recombinant potato virus X virus vectors presenting foreign epitopes

  2006cited by this paper
• Proteasome-Independent Major Histocompatibility Complex Class I Cross-Presentation Mediated by Papaya Mosaic Virus-Like Particles Leads to Expansion of Specific Human T Cells

  2006cited by this paper
• Immunoabsorbent nanoparticles based on a tobamovirus displaying protein A

  2006cited by this paper
• Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming1

  2006cited by this paper
• Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications.

  2006influential reference
• Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes.

  2006cited by this paper
• TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models.

  2006influential reference
• Immunogenic Properties of a Chimeric Plant Virus Expressing a Hepatitis C Virus (HCV)-Derived Epitope: New Prospects for an HCV Vaccine

  2005cited by this paper
• Immunogenicity in humans of an edible vaccine for hepatitis B.

  2005cited by this paper
• Systemic trafficking of plant virus nanoparticles in mice via the oral route.

  2005cited by this paper
• Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection

  2005cited by this paper
• Peptide-based candidate vaccine against respiratory syncytial virus.

  2005cited by this paper
• Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors1

  2004cited by this paper
• Heterologous expression of the modified coat protein of Cowpea chlorotic mottle bromovirus results in the assembly of protein cages with altered architectures and function.

  2004influential reference
• Expression of foot-and-mouth disease virus epitopes in tobacco by a tobacco mosaic virus-based vector.

  2003cited by this paper
• Effect of priming/booster immunisation protocols on immune response to canine parvovirus peptide induced by vaccination with a chimaeric plant virus construct.

  2003cited by this paper
• Cucumber mosaic virus as carrier of a hepatitis C virus-derived epitope

  2003cited by this paper
• Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

  2003cited by this paper
• Cowpea mosaic virus-based chimaeras. Effects of inserted peptides on the phenotype, host range, and transmissibility of the modified viruses.

  2003cited by this paper
• Characterization of the immune response to canine parvovirus induced by vaccination with chimaeric plant viruses.

  2002influential reference
• Cross‐presentation of virus‐like particles by skin‐derived CD8– dendritic cells: a dispensable role for TAP

  2002cited by this paper
• Novel Strategy for Inhibiting Viral Entry by Use of a Cellular Receptor-Plant Virus Chimera

  2002cited by this paper
• Critical Role for Activation of Antigen-Presenting Cells in Priming of Cytotoxic T Cell Responses After Vaccination with Virus-Like Particles1

  2002cited by this paper
• Identification of Immunogenic Hot Spots within Plum Pox Potyvirus Capsid Protein for Efficient Antigen Presentation

  2002cited by this paper
• Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus.

  2001influential reference

• Molecular Farming for Immunization: Current Advances and Future Prospects in Plant-Produced Vaccines

  2025cites this paper
• Advances in the Management of Infectious Diseases

  2025cites this paper
• The Use of Plant Viral Nanoparticles in Cancer Biotherapy—A Review

  2025cites this paper
• Functionalization of rod-shaped plant viruses for biomedical applications.

  2025cites this paper
• Systemic administration of a viral nanoparticle neoadjuvant prevents lung metastasis development through emergency myelopoiesis

  2024cites this paper
• Development of a Candidate TMV Epitope Display Vaccine against SARS-CoV-2

  2024influential citation
• Plant-based nanoparticles targeting malaria management

  2024cites this paper
• Plant-Derived Anti-Cancer Therapeutics and Biopharmaceuticals

  2024cites this paper
• Receptor agonist/antagonist-incorporated anticancer nanodrugs: Design, materials, and strategies

  2024cites this paper
• Recent advancements in the cancer vaccines: A review

  2024cites this paper
• Plant-based biopharmaceutical engineering

  2023cites this paper
• Plant Virus Nanoparticles Combat Cancer

  2023cites this paper
• COVID-19 vaccines based on viral nanoparticles displaying a conserved B-cell epitope show potent immunogenicity and a long-lasting antibody response

  2023cites this paper
• Plant-made vaccines against viral diseases in humans and farm animals

  2023cites this paper
• Bacterial expression systems based on Tymovirus-like particles for the presentation of vaccine antigens

  2023cites this paper
• Cauliflower mosaic virus: Virus-host interactions and its uses in biotechnology and medicine.

  2023cites this paper
• Self-Assembly of Flagellin into Immunostimulatory Ring-like Nanostructures as an Antigen Delivery System.

  2022cites this paper
• Modern vaccine strategies for emerging zoonotic viruses

  2022cites this paper
• Harnessing plant viruses in the metagenomics era: from the development of infectious clones to applications.

  2022cites this paper
• Suitability of potyviral recombinant virus-like particles bearing a complete food allergen for immunotherapy vaccines

  2022cites this paper
• Scientific Session of the General Meeting of the RAS Members “The Role of Science in Overcoming Pandemics and Postcrisis Development of Society” Plant Viruses: New Opportunities under the Pandemic

  2022cites this paper
• Multifunctional Plant Virus Nanoparticles for Targeting Breast Cancer Tumors

  2022cites this paper
• Self-adjuvanting cancer nanovaccines

  2022cites this paper
• Comparison of Bacterial Expression Systems Based on Potato Virus Y-like Particles for Vaccine Generation

  2022cites this paper
• Alfalfa mosaic virus nanoparticles-based in situ vaccination induces antitumor immune responses in breast cancer model.

  2021cites this paper
• MHC class I antigen cross-presentation mediated by PapMV nanoparticles in human antigen-presenting cells is dependent on autophagy

  2021cites this paper
• Integrating plant molecular farming and materials research for next-generation vaccines

  2021cites this paper
• Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors.

  2021cites this paper
• Viral Nanoparticle System: An Effective Platform for Photodynamic Therapy

  2021cites this paper
• The pharmacology of plant virus nanoparticles.

  2021cites this paper
• Plant virus particles with various shapes as potential adjuvants

  2020cites this paper
• Biomedical Applications of Viral Nanoparticles in Vaccine Therapy

  2020cites this paper
• Plant viral nanoparticles for packaging and in vivo delivery of bioactive cargos.

  2020cites this paper
• Research Progress in Bioinspired Drug Delivery Systems

  2020cites this paper
• Cowpea Mosaic Virus (CPMV)-Based Cancer Testis Antigen NY-ESO-1 Vaccine Elicits an Antigen-Specific Cytotoxic T Cell Response.

  2020cites this paper
• Advancements in protein nanoparticle vaccine platforms to combat infectious disease.

  2020cites this paper
• Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

  2019cites this paper
• Increased Immunogenicity of Full-Length Protein Antigens through Sortase-Mediated Coupling on the PapMV Vaccine Platform

  2019cites this paper
• Intracellular trafficking and endocytic uptake pathway of Pepper vein banding virus-like particles in epithelial cells.

  2019cites this paper
• Enhanced anti-tumor efficacy and reduced cardiotoxicity of doxorubicin delivered in a novel plant virus nanoparticle.

  2019cites this paper
• Protein-based nanoparticles in cancer vaccine development.

  2019cites this paper
• Use of plant viruses and virus-like particles for the creation of novel vaccines.

  2019cites this paper
• Efficacy of a Virus-Like Nanoparticle As Treatment for a Chronic Viral Infection Is Hindered by IRAK1 Regulation and Antibody Interference

  2018cites this paper
• Plant virus nanoparticles: Novel and robust nanocarriers for drug delivery and imaging.

  2018cites this paper
• Targeting Breast Cancer With Bio-inspired Virus Nanoparticles

  2018cites this paper
• Repurposing Plant Virus Nanoparticles

  2018cites this paper
• Viral nanoparticles: A drug delivery platform

  2018cites this paper
• Recombinant helical plant virus-based nanoparticles for vaccination and immunotherapy

  2018cites this paper
• History and Promise of Plant-Made Vaccines for Animals

  2018cites this paper
• Plant viruses and bacteriophages for drug delivery in medicine and biotechnology.

  2017cites this paper
• Viral nanoparticles: A drug delivery platform

  2017cites this paper
• A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling

  2017cites this paper
• Reconceptualizing cancer immunotherapy based on plant production systems

  2017cites this paper
• Complement Component 3 Regulates IFN-α Production by Plasmacytoid Dendritic Cells following TLR7 Activation by a Plant Virus–like Nanoparticle

  2017cites this paper
• Plastid Molecular Pharming I. Production of Oral Vaccines via Plastid Transformation.

  2017cites this paper
• Genetic Modifications of Icosahedral Plant Virus-based Nanoparticles for Vaccine and Immunotherapy Applications.

  2017cites this paper
• Physalis Mottle Virus-Like Particles as Nanocarriers for Imaging Reagents and Drugs.

  2017cites this paper
• Antibodies from plants for bionanomaterials.

  2017cites this paper
• Reduction Sensitive PEG Hydrogels for Codelivery of Antigen and Adjuvant To Induce Potent CTLs.

  2016cites this paper
• Plant-Based Vaccines: Production and Challenges

  2016cites this paper
• Biosafety of plant viruses for human and animals

  2016cites this paper
• Self-assembly of hexahistidine-tagged tobacco etch virus capsid protein into microfilaments that induce IgG2-specific response against a soluble porcine reproductive and respiratory syndrome virus chimeric protein

  2016cites this paper
• Linked CD4 T Cell Help: Broadening Immune Attack Against Cancer by Vaccination.

  2016cites this paper
• Chimeric particles of tobacco mosaic virus as a platform for the development of next-generation nanovaccines

  2016cites this paper
• Potentiating Cancer Immunotherapy Using Papaya Mosaic Virus-Derived Nanoparticles.

  2016cites this paper
• The Two-Faced Potato Virus X: From Plant Pathogen to Smart Nanoparticle

  2015cites this paper